THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

FDA to hear views on drugs' suicide link

By Carey Goldberg
Globe Staff / February 2, 2004

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

  • E-mail|
  • Print|
  • Reprints|
  • |
Text size +

After her 11-year-old son began taking the antidepressant Lexapro this summer, Yvette Prayor of Worcester found herself pacing the floors at night. (Full Article: 1253 Words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 Article
  • $9.95 4 Articles
  • $99.95 Unlimited

Connect with Boston.com

Twitter Follow us on @BostonUpdate, other Twitter accounts